Go Pro
→ Your $29.97 book is free today (From Profits Run) (Ad)tc pixel Free VHI Stock Alerts

Vitalhub (VHI) Competitors

Vitalhub logo
C$7.36 -0.25 (-3.29%)
As of 09/24/2026 04:00 PM Eastern
Compare

VHI vs. CARE, ADK, RHT, DOC, and ZMD

Should you buy Vitalhub stock or one of its competitors? Vitalhub's main competitors and comparable companies include Dialogue Health Technologies (CARE), DIAGNOS (ADK), Reliq Health Technologies (RHT), CloudMD Software & Services (DOC), and ZoomMed (ZMD). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare technology" industry.

How does Vitalhub compare to Dialogue Health Technologies?

Dialogue Health Technologies (TSE:CARE) and Vitalhub (TSE:VHI) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their profitability, valuation, risk, media sentiment, analyst recommendations, institutional ownership, earnings and dividends.

In the previous week, Dialogue Health Technologies had 2 more articles in the media than Vitalhub. MarketBeat recorded 2 mentions for Dialogue Health Technologies and 0 mentions for Vitalhub. Dialogue Health Technologies' average media sentiment score of 0.00 equaled Vitalhub'saverage media sentiment score.

Company Overall Sentiment
Dialogue Health Technologies Neutral
Vitalhub Neutral

Vitalhub has a consensus target price of C$13.00, suggesting a potential upside of 76.63%. Given Vitalhub's stronger consensus rating and higher probable upside, analysts plainly believe Vitalhub is more favorable than Dialogue Health Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Dialogue Health Technologies
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Vitalhub
0 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
3.14

Dialogue Health Technologies has a beta of 2.66, indicating that its share price is 166% more volatile than the broader market. Comparatively, Vitalhub has a beta of 1.136195, indicating that its share price is 14% more volatile than the broader market.

47.0% of Dialogue Health Technologies shares are held by institutional investors. Comparatively, 25.1% of Vitalhub shares are held by institutional investors. 11.7% of Dialogue Health Technologies shares are held by company insiders. Comparatively, 18.6% of Vitalhub shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Vitalhub has a net margin of 5.89% compared to Dialogue Health Technologies' net margin of -19.73%. Vitalhub's return on equity of 2.79% beat Dialogue Health Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Dialogue Health Technologies-19.73% -19.76% -10.01%
Vitalhub 5.89%2.79%3.81%

Vitalhub has higher revenue and earnings than Dialogue Health Technologies. Dialogue Health Technologies is trading at a lower price-to-earnings ratio than Vitalhub, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Dialogue Health TechnologiesC$95.88M0.00-C$19.50M-C$0.30N/A
VitalhubC$127.08M3.67C$3.35MC$0.1261.33

Summary

Vitalhub beats Dialogue Health Technologies on 12 of the 15 factors compared between the two stocks.

How does Vitalhub compare to DIAGNOS?

DIAGNOS (CVE:ADK) and Vitalhub (TSE:VHI) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, earnings, analyst recommendations, valuation, institutional ownership, dividends, risk and media sentiment.

Vitalhub has a consensus price target of C$13.00, indicating a potential upside of 76.63%. Given Vitalhub's stronger consensus rating and higher possible upside, analysts clearly believe Vitalhub is more favorable than DIAGNOS.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
DIAGNOS
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Vitalhub
0 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
3.14

In the previous week, DIAGNOS's average media sentiment score of 0.00 equaled Vitalhub'saverage media sentiment score.

Company Overall Sentiment
DIAGNOS Neutral
Vitalhub Neutral

Vitalhub has a net margin of 5.89% compared to DIAGNOS's net margin of -6,956.84%. DIAGNOS's return on equity of 11,659.44% beat Vitalhub's return on equity.

Company Net Margins Return on Equity Return on Assets
DIAGNOS-6,956.84% 11,659.44% -134.33%
Vitalhub 5.89%2.79%3.81%

DIAGNOS has a beta of 0.500906, suggesting that its share price is 50% less volatile than the broader market. Comparatively, Vitalhub has a beta of 1.136195, suggesting that its share price is 14% more volatile than the broader market.

Vitalhub has higher revenue and earnings than DIAGNOS. DIAGNOS is trading at a lower price-to-earnings ratio than Vitalhub, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
DIAGNOSC$65.48K887.29-C$3.81M-C$0.04N/A
VitalhubC$127.08M3.67C$3.35MC$0.1261.33

0.3% of DIAGNOS shares are owned by institutional investors. Comparatively, 25.1% of Vitalhub shares are owned by institutional investors. 16.8% of DIAGNOS shares are owned by insiders. Comparatively, 18.6% of Vitalhub shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Vitalhub beats DIAGNOS on 13 of the 15 factors compared between the two stocks.

How does Vitalhub compare to Reliq Health Technologies?

Vitalhub (TSE:VHI) and Reliq Health Technologies (CVE:RHT) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, dividends, media sentiment, analyst recommendations, institutional ownership, earnings, risk and profitability.

Vitalhub has a net margin of 5.89% compared to Reliq Health Technologies' net margin of -95.54%. Vitalhub's return on equity of 2.79% beat Reliq Health Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Vitalhub5.89% 2.79% 3.81%
Reliq Health Technologies -95.54%-221.64%-5.30%

Vitalhub presently has a consensus price target of C$13.00, suggesting a potential upside of 76.63%. Given Vitalhub's stronger consensus rating and higher possible upside, equities research analysts clearly believe Vitalhub is more favorable than Reliq Health Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Vitalhub
0 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
3.14
Reliq Health Technologies
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Vitalhub has higher revenue and earnings than Reliq Health Technologies. Reliq Health Technologies is trading at a lower price-to-earnings ratio than Vitalhub, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
VitalhubC$127.08M3.67C$3.35MC$0.1261.33
Reliq Health TechnologiesN/AN/AN/A-C$0.02N/A

25.1% of Vitalhub shares are owned by institutional investors. Comparatively, 2.8% of Reliq Health Technologies shares are owned by institutional investors. 18.6% of Vitalhub shares are owned by insiders. Comparatively, 1.8% of Reliq Health Technologies shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Vitalhub has a beta of 1.136195, suggesting that its share price is 14% more volatile than the broader market. Comparatively, Reliq Health Technologies has a beta of 1.64, suggesting that its share price is 64% more volatile than the broader market.

In the previous week, Vitalhub's average media sentiment score of 0.00 equaled Reliq Health Technologies'average media sentiment score.

Company Overall Sentiment
Vitalhub Neutral
Reliq Health Technologies Neutral

Summary

Vitalhub beats Reliq Health Technologies on 12 of the 13 factors compared between the two stocks.

How does Vitalhub compare to CloudMD Software & Services?

Vitalhub (TSE:VHI) and CloudMD Software & Services (CVE:DOC) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, valuation, risk, earnings and media sentiment.

Vitalhub presently has a consensus target price of C$13.00, suggesting a potential upside of 76.63%. Given Vitalhub's stronger consensus rating and higher probable upside, research analysts plainly believe Vitalhub is more favorable than CloudMD Software & Services.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Vitalhub
0 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
3.14
CloudMD Software & Services
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Vitalhub has higher revenue and earnings than CloudMD Software & Services. CloudMD Software & Services is trading at a lower price-to-earnings ratio than Vitalhub, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
VitalhubC$127.08M3.67C$3.35MC$0.1261.33
CloudMD Software & ServicesC$90.91M0.12-C$76.56M-C$0.23N/A

In the previous week, Vitalhub's average media sentiment score of 0.00 equaled CloudMD Software & Services'average media sentiment score.

Company Overall Sentiment
Vitalhub Neutral
CloudMD Software & Services Neutral

25.1% of Vitalhub shares are owned by institutional investors. Comparatively, 0.5% of CloudMD Software & Services shares are owned by institutional investors. 18.6% of Vitalhub shares are owned by company insiders. Comparatively, 0.1% of CloudMD Software & Services shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Vitalhub has a beta of 1.136195, indicating that its share price is 14% more volatile than the broader market. Comparatively, CloudMD Software & Services has a beta of 1.26, indicating that its share price is 26% more volatile than the broader market.

Vitalhub has a net margin of 5.89% compared to CloudMD Software & Services' net margin of -91.12%. Vitalhub's return on equity of 2.79% beat CloudMD Software & Services' return on equity.

Company Net Margins Return on Equity Return on Assets
Vitalhub5.89% 2.79% 3.81%
CloudMD Software & Services -91.12%-102.91%-8.74%

Summary

Vitalhub beats CloudMD Software & Services on 14 of the 15 factors compared between the two stocks.

How does Vitalhub compare to ZoomMed?

ZoomMed (CVE:ZMD) and Vitalhub (TSE:VHI) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, dividends, analyst recommendations, earnings, media sentiment, institutional ownership and profitability.

Vitalhub has higher revenue and earnings than ZoomMed. ZoomMed is trading at a lower price-to-earnings ratio than Vitalhub, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ZoomMedC$10K203.39-C$1.49M-C$0.01N/A
VitalhubC$127.08M3.67C$3.35MC$0.1261.33

In the previous week, ZoomMed's average media sentiment score of 0.00 equaled Vitalhub'saverage media sentiment score.

Company Overall Sentiment
ZoomMed Neutral
Vitalhub Neutral

25.1% of Vitalhub shares are held by institutional investors. 18.6% of Vitalhub shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Vitalhub has a net margin of 5.89% compared to ZoomMed's net margin of 0.00%. Vitalhub's return on equity of 2.79% beat ZoomMed's return on equity.

Company Net Margins Return on Equity Return on Assets
ZoomMedN/A N/A N/A
Vitalhub 5.89%2.79%3.81%

Vitalhub has a consensus price target of C$13.00, indicating a potential upside of 76.63%. Given Vitalhub's stronger consensus rating and higher possible upside, analysts plainly believe Vitalhub is more favorable than ZoomMed.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ZoomMed
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Vitalhub
0 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
3.14

Summary

Vitalhub beats ZoomMed on 13 of the 14 factors compared between the two stocks.

Get Vitalhub News Delivered to You Automatically

Sign up to receive the latest news and ratings for VHI and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding VHI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VHI vs. The Competition

Export
MetricVitalhubHealthcare Technology IndustryHealthcare SectorTSE Exchange
Market CapC$482.01MC$1.72BC$7.32BC$12.53B
Dividend YieldN/A3.89%2.52%6.28%
P/E Ratio61.3320.76274.3939.99
Price / Sales3.6788.51688.889.14
Price / CashN/A31.7277.8082.29
Price / Book1.706.1310.474.67
Net IncomeC$3.35M-C$18.66MC$3.49BC$299.09M
7 Day PerformanceN/A-1.30%-0.91%-0.37%
1 Month Performance-7.54%1.11%-4.21%-2.74%
1 Year Performance-33.99%-16.27%16.39%19.83%

Vitalhub Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VHI
Vitalhub
N/AC$7.36
-3.3%		C$13.00
+76.6%		-35.2%C$482.01MC$127.08M61.33700
CARE
Dialogue Health Technologies
N/AN/AN/AN/AC$345.36MC$95.88MN/A730
ADK
DIAGNOS
N/AC$0.49
-3.9%		N/A+84.6%C$59.31MC$65.48KN/AN/A
RHT
Reliq Health Technologies
N/AC$0.22
flat		N/A+0.0%C$46.65MN/AN/A12,600
DOC
CloudMD Software & Services
N/AC$0.04
flat		N/A+0.0%C$10.66MC$90.91MN/A200

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (TSE:VHI) was last updated on 9/25/2026 by MarketBeat.com Staff.
From Our Partners
Trump's New Dollar
Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...
Porter & Company | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...
The Oxford Club | Sponsoredtc pixel
Bank of America: 'Digital Dollar Inevitable'
Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...
Decentralized Masters | Sponsoredtc pixel
These gold assets are priced for $1,800 gold [it's over $4,000]
Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's...
Golden Portfolio | Sponsoredtc pixel
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...
Profits Run | Sponsoredtc pixel